Form 483

Navajo Manufacturing Company Form 483, 2013-07-09

FDA issued a Form 483 to Navajo Manufacturing Company on 2013-07-09 with 9 public-safe observations.

483· Form 483 issuedHuman Drugs9 observations

Navajo Manufacturing Company · Denver, United States · Issued July 9, 2013

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

9 Jul 2013
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Edith M Gonzalez, Isabel Y Espinosa

9 Jul 2013
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Edith M Gonzalez, Isabel Y Espinosa

9 Jul 2013
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Edith M Gonzalez, Isabel Y Espinosa

9 Jul 2013
21 CFR 211.82(a)

Examination on receipt, before acceptance

Cited by Edith M Gonzalez, Isabel Y Espinosa

9 Jul 2013
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Edith M Gonzalez, Isabel Y Espinosa

Inspected site

NMNavajo Manufacturing CompanyDenver, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.115(b)Cited across public-safe Form 483 observations1x
21 CFR 211.125(a)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.82(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere